Fare Capital is an impact investment firm established in 2017 and located in Oegstgeest, Netherlands. The firm specializes in providing funding solutions and private equity investments, with a focus on mentoring small and medium-sized enterprises in the food and healthcare sectors. Through its strategic investments, Fare Capital aims to support the growth and development of businesses that contribute positively to society while achieving financial returns.
MyLife Technologies develops a platform technology based on nanoporous micro-needle arrays embedded in patches for transdermal delivery of vaccines and drugs. The company, founded in 2012 and headquartered in Leiden, Netherlands, is focused on ceramic microneedle arrays and intelligent skin patches that enable intradermal administration. The technology aims to improve vaccine delivery efficiency compared with intramuscular injections, eliminate the need for cold-chain logistics, and provide a painless experience for patients. With patented nano-porous ceramic materials, the company pursues rapid deployment for outbreak responses and broader therapeutic applications. Through collaboration with partners, MyLife Technologies seeks to advance scalable patch-based delivery solutions that combine comfort, ease of use, and performance in immunization and treatment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.